179 related articles for article (PubMed ID: 37884178)
21. Exogenous progestins and breast cancer.
Stanford JL; Thomas DB
Epidemiol Rev; 1993; 15(1):98-107. PubMed ID: 8405216
[TBL] [Abstract][Full Text] [Related]
22. Risk factors for hormone receptor-defined breast cancer in postmenopausal women.
Rosenberg LU; Einarsdóttir K; Friman EI; Wedrén S; Dickman PW; Hall P; Magnusson C
Cancer Epidemiol Biomarkers Prev; 2006 Dec; 15(12):2482-8. PubMed ID: 17164374
[TBL] [Abstract][Full Text] [Related]
23. Progestin-dependent induction of vascular endothelial growth factor in human breast cancer cells: preferential regulation by progesterone receptor B.
Wu J; Richer J; Horwitz KB; Hyder SM
Cancer Res; 2004 Mar; 64(6):2238-44. PubMed ID: 15026368
[TBL] [Abstract][Full Text] [Related]
24. PRMT1, a Key Modulator of Unliganded Progesterone Receptor Signaling in Breast Cancer.
Malbeteau L; Jacquemetton J; Languilaire C; Corbo L; Le Romancer M; Poulard C
Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36076907
[TBL] [Abstract][Full Text] [Related]
25. Functions of Membrane Progesterone Receptors (mPRs, PAQRs) in Nonreproductive Tissues.
Thomas P; Pang Y; Camilletti MA; Castelnovo LF
Endocrinology; 2022 Oct; 163(11):. PubMed ID: 36041040
[TBL] [Abstract][Full Text] [Related]
26. Phosphorylation-dependent antagonism of sumoylation derepresses progesterone receptor action in breast cancer cells.
Daniel AR; Faivre EJ; Lange CA
Mol Endocrinol; 2007 Dec; 21(12):2890-906. PubMed ID: 17717077
[TBL] [Abstract][Full Text] [Related]
27. Progesterone and breast cancer.
Lange CA; Yee D
Womens Health (Lond); 2008 Mar; 4(2):151-62. PubMed ID: 19072517
[TBL] [Abstract][Full Text] [Related]
28. The role of sex hormones and steroid receptors on female reproductive cancers.
Chuffa LG; Lupi-Júnior LA; Costa AB; Amorim JP; Seiva FR
Steroids; 2017 Feb; 118():93-108. PubMed ID: 28041951
[TBL] [Abstract][Full Text] [Related]
29. Progesterone receptor rapid signaling mediates serine 345 phosphorylation and tethering to specificity protein 1 transcription factors.
Faivre EJ; Daniel AR; Hillard CJ; Lange CA
Mol Endocrinol; 2008 Apr; 22(4):823-37. PubMed ID: 18202149
[TBL] [Abstract][Full Text] [Related]
30. Expression of membrane progesterone receptors (mPR/PAQR) in ovarian cancer cells: implications for progesterone-induced signaling events.
Charles NJ; Thomas P; Lange CA
Horm Cancer; 2010 Aug; 1(4):167-76. PubMed ID: 21761364
[TBL] [Abstract][Full Text] [Related]
31. Signaling inputs to progesterone receptor gene regulation and promoter selectivity.
Daniel AR; Knutson TP; Lange CA
Mol Cell Endocrinol; 2009 Sep; 308(1-2):47-52. PubMed ID: 19549591
[TBL] [Abstract][Full Text] [Related]
32. Role of the short isoform of the progesterone receptor in breast cancer cell invasiveness at estrogen and progesterone levels in the pre- and post-menopausal ranges.
McFall T; Patki M; Rosati R; Ratnam M
Oncotarget; 2015 Oct; 6(32):33146-64. PubMed ID: 26356672
[TBL] [Abstract][Full Text] [Related]
33. Genomic agonism and phenotypic antagonism between estrogen and progesterone receptors in breast cancer.
Singhal H; Greene ME; Tarulli G; Zarnke AL; Bourgo RJ; Laine M; Chang YF; Ma S; Dembo AG; Raj GV; Hickey TE; Tilley WD; Greene GL
Sci Adv; 2016 Jun; 2(6):e1501924. PubMed ID: 27386569
[TBL] [Abstract][Full Text] [Related]
34. Progesterone, progestins and the breast in menopause treatment.
Gompel A; Plu-Bureau G
Climacteric; 2018 Aug; 21(4):326-332. PubMed ID: 29852797
[TBL] [Abstract][Full Text] [Related]
35. Targeting progesterone receptors in breast cancer.
Giulianelli S; Molinolo A; Lanari C
Vitam Horm; 2013; 93():161-84. PubMed ID: 23810006
[TBL] [Abstract][Full Text] [Related]
36. Hypothesis: Progesterone primes breast cancer cells for cross-talk with proliferative or antiproliferative signals.
Lange CA; Richer JK; Horwitz KB
Mol Endocrinol; 1999 Jun; 13(6):829-36. PubMed ID: 10379882
[TBL] [Abstract][Full Text] [Related]
37. Progesterone receptor action: translating studies in breast cancer models to clinical insights.
Lange CA; Sartorius CA; Abdel-Hafiz H; Spillman MA; Horwitz KB; Jacobsen BM
Adv Exp Med Biol; 2008; 630():94-111. PubMed ID: 18637487
[TBL] [Abstract][Full Text] [Related]
38. Luminal breast cancer metastases and tumor arousal from dormancy are promoted by direct actions of estradiol and progesterone on the malignant cells.
Ogba N; Manning NG; Bliesner BS; Ambler SK; Haughian JM; Pinto MP; Jedlicka P; Joensuu K; Heikkilä P; Horwitz KB
Breast Cancer Res; 2014 Dec; 16(6):489. PubMed ID: 25475897
[TBL] [Abstract][Full Text] [Related]
39. Progesterone and levonorgestrel regulate expression of 17βHSD-enzymes in progesterone receptor positive breast cancer cell line T47D.
Sivik T; Jansson A
Biochem Biophys Res Commun; 2012 May; 422(1):109-13. PubMed ID: 22564730
[TBL] [Abstract][Full Text] [Related]
40. A biological marker, strongly associated with early oral contraceptive use, for the selection of a high risk group for premenopausal breast cancer.
Olsson H; Borg A; Ewers SB; Fernö M; Möller T; Ranstam J
Med Oncol Tumor Pharmacother; 1986; 3(2):77-81. PubMed ID: 3747639
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
